Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 4Neuroendocrine Tumors 2Lymphoma 2Hodgkin Disease 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Rectal Neoplasms 1Prostate Cancer Metastatic 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Leukemia 1Hypoxia 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Lobular 1Cancer Diagnosis 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

cabazitaxel 3Trastuzumab 3Cyclophosphamide 2Cetuximab 2Carboplatin 2Aspirin 2ribociclib 1pertuzumab 1eribulin 1Thiotepa 1Taxes 1Stem Cell Transplantation 1Propofol 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Neoadjuvant Therapy 1Liquid Biopsy 1Letrozole 1Ipilimumab 1Histamine H2 Antagonists 1Histamine Antagonists 1Gemcitabine 1Fulvestrant 1Epirubicin 1Docetaxel 1Denosumab 1Circulating Tumor DNA 1Cell-Free Nucleic Acids 1CA-72-4 antigen 1CA-19-9 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neoplastic Cells, Circulating × Positron Emission Tomography Computed Tomography × Clear all
NCT06067503 2026-04-13

Biomarkers to Detect Endocrine Therapy Resistance

University of Wisconsin, Madison

Phase 2 Recruiting
8 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡